241 related articles for article (PubMed ID: 15501241)
1. Direct chemotactic action of angiopoietin-1 on mesenchymal cells in the presence of VEGF.
Metheny-Barlow LJ; Tian S; Hayes AJ; Li LY
Microvasc Res; 2004 Nov; 68(3):221-30. PubMed ID: 15501241
[TBL] [Abstract][Full Text] [Related]
2. Rat aorta-derived mural precursor cells express the Tie2 receptor and respond directly to stimulation by angiopoietins.
Iurlaro M; Scatena M; Zhu WH; Fogel E; Wieting SL; Nicosia RF
J Cell Sci; 2003 Sep; 116(Pt 17):3635-43. PubMed ID: 12876214
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin-1 alters tumor growth by stabilizing blood vessels or by promoting angiogenesis.
Satoh N; Yamada Y; Kinugasa Y; Takakura N
Cancer Sci; 2008 Dec; 99(12):2373-9. PubMed ID: 19018775
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment.
Holopainen T; Huang H; Chen C; Kim KE; Zhang L; Zhou F; Han W; Li C; Yu J; Wu J; Koh GY; Alitalo K; He Y
Cancer Res; 2009 Jun; 69(11):4656-64. PubMed ID: 19487284
[TBL] [Abstract][Full Text] [Related]
5. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.
Grosskreutz CL; Anand-Apte B; Dupláa C; Quinn TP; Terman BI; Zetter B; D'Amore PA
Microvasc Res; 1999 Sep; 58(2):128-36. PubMed ID: 10458928
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay.
Ley CD; Olsen MW; Lund EL; Kristjansen PE
Microvasc Res; 2004 Nov; 68(3):161-8. PubMed ID: 15501235
[TBL] [Abstract][Full Text] [Related]
8. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
[TBL] [Abstract][Full Text] [Related]
9. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice.
Amano K; Okigaki M; Adachi Y; Fujiyama S; Mori Y; Kosaki A; Iwasaka T; Matsubara H
J Mol Cell Cardiol; 2004 Apr; 36(4):469-80. PubMed ID: 15081307
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin1/Tie2 and VEGF/Flk1 induced by MSC treatment amplifies angiogenesis and vascular stabilization after stroke.
Zacharek A; Chen J; Cui X; Li A; Li Y; Roberts C; Feng Y; Gao Q; Chopp M
J Cereb Blood Flow Metab; 2007 Oct; 27(10):1684-91. PubMed ID: 17356562
[TBL] [Abstract][Full Text] [Related]
11. Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway.
DeBusk LM; Hallahan DE; Lin PC
Exp Cell Res; 2004 Aug; 298(1):167-77. PubMed ID: 15242771
[TBL] [Abstract][Full Text] [Related]
12. Expressions of angiopoietins and Tie2 in human choroidal neovascular membranes.
Otani A; Takagi H; Oh H; Koyama S; Matsumura M; Honda Y
Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1912-20. PubMed ID: 10440243
[TBL] [Abstract][Full Text] [Related]
13. The enigmatic role of angiopoietin-1 in tumor angiogenesis.
Metheny-Barlow LJ; Li LY
Cell Res; 2003 Oct; 13(5):309-17. PubMed ID: 14672554
[TBL] [Abstract][Full Text] [Related]
14. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy.
Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
Transplant Proc; 2008 Oct; 40(8):2795-9. PubMed ID: 18929864
[TBL] [Abstract][Full Text] [Related]
15. IL-3 affects endothelial cell-mediated smooth muscle cell recruitment by increasing TGF beta activity: potential role in tumor vessel stabilization.
Dentelli P; Rosso A; Calvi C; Ghiringhello B; Garbarino G; Camussi G; Pegoraro L; Brizzi MF
Oncogene; 2004 Mar; 23(9):1681-92. PubMed ID: 14755254
[TBL] [Abstract][Full Text] [Related]
16. NERF2, a member of the Ets family of transcription factors, is increased in response to hypoxia and angiopoietin-1: a potential mechanism for Tie2 regulation during hypoxia.
Christensen RA; Fujikawa K; Madore R; Oettgen P; Varticovski L
J Cell Biochem; 2002; 85(3):505-15. PubMed ID: 11967990
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells.
Hangai M; Murata T; Miyawaki N; Spee C; Lim JI; He S; Hinton DR; Ryan SJ
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1617-25. PubMed ID: 11381069
[TBL] [Abstract][Full Text] [Related]
18. Priming with angiopoietin-1 augments the vasculogenic potential of the peripheral blood stem cells mobilized with granulocyte colony-stimulating factor through a novel Tie2/Ets-1 pathway.
Kim MS; Lee CS; Hur J; Cho HJ; Jun SI; Kim TY; Lee SW; Suh JW; Park KW; Lee HY; Kang HJ; Lee DS; Koh GY; Nakagami H; Morishita R; Park YB; Kim HS
Circulation; 2009 Dec; 120(22):2240-50. PubMed ID: 19917886
[TBL] [Abstract][Full Text] [Related]
19. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
[TBL] [Abstract][Full Text] [Related]
20. Acute resistance exercise increases skeletal muscle angiogenic growth factor expression.
Gavin TP; Drew JL; Kubik CJ; Pofahl WE; Hickner RC
Acta Physiol (Oxf); 2007 Oct; 191(2):139-46. PubMed ID: 17565567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
